Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
- Accession Number
- DB10991
- Description
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects the mucosal layers of the human respiratory tract.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Toxoid - Synonyms
- Bordetella pertussis toxoid vaccine, inactivated
Pharmacology
- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Mixture Products
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- QSN5XO8ZSU
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Active Not Recruiting Prevention Human Papillomavirus Infections / Human Papillomavirus-Related Cervical Carcinoma 1 4 Completed Prevention Acellular Pertussis / Diphtheria / Diphtheria-Tetanus-acellular Pertussis Vaccines / Tetanus 1 4 Completed Prevention Acellular Pertussis / Diphtheria / Haemophilus Influenzae Type B / Poliomyelitis / Tetanus / Viral Hepatitis B 2 4 Completed Prevention Acellular Pertussis / Diphtheria / Poliomyelitis / Tetanus 1 4 Completed Prevention Acellular Pertussis / Diphtheria / Poliomyelitis / Tetanus / Viral Hepatitis B 1 4 Completed Prevention Acellular Pertussis / Diphtheria / Tetanus 5 4 Completed Prevention BCG Infection / Immune Response / Reaction - Vaccine 1 4 Completed Prevention Diphtheria-Tetanus-acellular Pertussis Vaccines 1 4 Completed Prevention Diphtheria / Pertussis / Poliomyelitis / Tetanus 1 4 Completed Prevention Diphtheria / Pertussis / Tetanus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intramuscular 2 Lf/0.5mL Injection, suspension Intramuscular 2 Lf/0.5mL Injection, suspension Intramuscular 8 ug/0.5mL Suspension Intramuscular 2 IU/0.5ml Injection, suspension Intramuscular 8 mcg/0.5ml Injection, suspension Intramuscular 2.5 mcg Injection, suspension Intramuscular 4 IU/0.5ml Injection, solution Intramuscular 20 IU Injection, suspension Intramuscular 25 mcg/0.5ml Injection, suspension Intramuscular 25 ug/0.5mL Suspension Intramuscular Injection, powder, for suspension Intramuscular 25 mcg/0.5ml Injection, suspension Intramuscular 40 [D'ag'U]/0.5mL Injection, suspension Intramuscular Injection, powder, for suspension Intramuscular 30 IU/0.5ml Injection Intramuscular 30 IU Injection, suspension Intramuscular 30 IU/0.5ml Injection, suspension Intramuscular 2 IU Injection, suspension Intramuscular; Subcutaneous 2 IU/0.5ml - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 01, 2015 13:04 / Updated on June 12, 2020 10:53